Home

Ik heb een contract gemaakt Ik was verrast Ideaal mmr vaccine 2 doses België vinger geschiedenis aluminium

Vaccines | Free Full-Text | Risk of Absence of Measles Antibody in  Healthcare Personnel and Efficacy of Booster Vaccination | HTML
Vaccines | Free Full-Text | Risk of Absence of Measles Antibody in Healthcare Personnel and Efficacy of Booster Vaccination | HTML

First doses donated by Belgium through COVAX arrive to Armenia | Gavi, the  Vaccine Alliance
First doses donated by Belgium through COVAX arrive to Armenia | Gavi, the Vaccine Alliance

References in Protection against varicella with two doses of combined  measles-mumps-rubella-varicella vaccine versus one dose of monovalent varicella  vaccine: a multicentre, observer-blind, randomised, controlled trial - The  Lancet
References in Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine versus one dose of monovalent varicella vaccine: a multicentre, observer-blind, randomised, controlled trial - The Lancet

Belgian regulators advise against giving AstraZeneca Covid vaccine to  over-55s | Belgium | The Guardian
Belgian regulators advise against giving AstraZeneca Covid vaccine to over-55s | Belgium | The Guardian

Frontiers | Repurposing Infectious Diseases Vaccines Against Cancer |  Oncology
Frontiers | Repurposing Infectious Diseases Vaccines Against Cancer | Oncology

The Effect of Maternal Immunisation During Pregnancy on Infant Vaccine  Responses - EClinicalMedicine
The Effect of Maternal Immunisation During Pregnancy on Infant Vaccine Responses - EClinicalMedicine

Amerikanen mogen zelf vaccin kiezen voor extra prik. Hoe werkt het?
Amerikanen mogen zelf vaccin kiezen voor extra prik. Hoe werkt het?

Safety and immunogenicity of the measles vector-based SARS-CoV-2 vaccine  candidate, V591, in adults: results from a phase 1/2 randomised,  double-blind, placebo-controlled, dose-ranging trial - eBioMedicine
Safety and immunogenicity of the measles vector-based SARS-CoV-2 vaccine candidate, V591, in adults: results from a phase 1/2 randomised, double-blind, placebo-controlled, dose-ranging trial - eBioMedicine

Opening van het grootste Belgische vaccinatiecentrum op de Heizel |  Gemeenschappelijke Gemeenschapscommissie
Opening van het grootste Belgische vaccinatiecentrum op de Heizel | Gemeenschappelijke Gemeenschapscommissie

Coronavaccin veilig en werkzaam bij kinderen van 5 tot 11 jaar", maar lang  niet zeker of we hen ook zullen vaccineren | VRT NWS: nieuws
Coronavaccin veilig en werkzaam bij kinderen van 5 tot 11 jaar", maar lang niet zeker of we hen ook zullen vaccineren | VRT NWS: nieuws

Een stand van zaken - Vax Info
Een stand van zaken - Vax Info

SciELO - Saúde Pública - Comparison of rubella seroepidemiology in 17  countries: progress towards international disease control targets  Comparison of rubella seroepidemiology in 17 countries: progress towards  international disease control targets
SciELO - Saúde Pública - Comparison of rubella seroepidemiology in 17 countries: progress towards international disease control targets Comparison of rubella seroepidemiology in 17 countries: progress towards international disease control targets

EU drug regulator reviewing woman's death in Belgium after getting J&J shot  – EURACTIV.com
EU drug regulator reviewing woman's death in Belgium after getting J&J shot – EURACTIV.com

Safety and immunogenicity of a measles-vectored SARS-CoV-2 vaccine  candidate, V591 / TMV-083, in healthy adults: results of a randomized,  placebo-controlled Phase I study - eBioMedicine
Safety and immunogenicity of a measles-vectored SARS-CoV-2 vaccine candidate, V591 / TMV-083, in healthy adults: results of a randomized, placebo-controlled Phase I study - eBioMedicine

Het vaccindilemma: is het individuele risico op bijwerkingen belangrijker,  of het algemeen belang?
Het vaccindilemma: is het individuele risico op bijwerkingen belangrijker, of het algemeen belang?

Nuvaxovid alternatief voor mensen die niet tegen Covid-19 konden  gevaccineerd worden | Zorgnet-Icuro
Nuvaxovid alternatief voor mensen die niet tegen Covid-19 konden gevaccineerd worden | Zorgnet-Icuro

EU drug regulator positive on early data on mixing coronavirus vaccines –  POLITICO
EU drug regulator positive on early data on mixing coronavirus vaccines – POLITICO

Belgium to give booster coronavirus vaccines for immunocompromised –  POLITICO
Belgium to give booster coronavirus vaccines for immunocompromised – POLITICO

Vaccination | Coronavirus COVID-19
Vaccination | Coronavirus COVID-19

Vaccinations in Belgium: the Belgian vaccine schedule | Expatica
Vaccinations in Belgium: the Belgian vaccine schedule | Expatica

Dringende brief 4 : Tweede dosis Vaxzevria® en algemene voorwaarden  COVID-19 Vaccine Janssen® | FOD Volksgezondheid
Dringende brief 4 : Tweede dosis Vaxzevria® en algemene voorwaarden COVID-19 Vaccine Janssen® | FOD Volksgezondheid

The Impact of 2-Dose Routine Measles, Mumps, Rubella, and Varicella  Vaccination in France on the Epidemiology of Varicella and Zoster Using a  Dynamic Model With an Empirical Contact Matrix - Clinical Therapeutics
The Impact of 2-Dose Routine Measles, Mumps, Rubella, and Varicella Vaccination in France on the Epidemiology of Varicella and Zoster Using a Dynamic Model With an Empirical Contact Matrix - Clinical Therapeutics

Belgium to stop giving Oxford/AstraZeneca vaccine to people under 56 –  POLITICO
Belgium to stop giving Oxford/AstraZeneca vaccine to people under 56 – POLITICO

Beslissing over boosters bij min 18-jarigen opnieuw uitgesteld | De  Standaard Mobile
Beslissing over boosters bij min 18-jarigen opnieuw uitgesteld | De Standaard Mobile

1.238 foto's en beelden met Mmr - Getty Images
1.238 foto's en beelden met Mmr - Getty Images

Coronavirus: de meest gestelde vragen over de impact op je onderneming |  Voka
Coronavirus: de meest gestelde vragen over de impact op je onderneming | Voka

Preventive care - For a Healthy Belgium
Preventive care - For a Healthy Belgium